Trial Outcomes & Findings for Renal Safety of Bowel Preparation With Polyethylene Glycol (NCT NCT02657564)

NCT ID: NCT02657564

Last Updated: 2019-02-05

Results Overview

The screening visit (visit 1) induced a blood specimen for serum chemistry analysis. Immediately before the colonoscopy, study staff collected blood specimens for chemistry analysis (visit 2). The patients returned within 28 days after the colonoscopy for a final renal test (visit 3). Patients with a ≥30% increase above baseline creatinine levels during visit 2 or 3 were followed every 2-4 weeks until a peak level was detected (visit 4 and beyond).The serum creatinine level on visit 1 was recorded as the baseline renal function. The presence of renal injuries was determined by the highest serum creatinine level noted during the study period and included acute renal dysfunction, defined as a 30-49% increase above the baseline creatinine level, and acute kidney injury, defined as a ≥50% increase above the baseline serum creatinine. Number of participants with acute renal injury which included acute renal dysfunction and acute kidney injury will be recorded.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

1237 participants

Primary outcome timeframe

The durations between visits 1-2 and visits 2-3 were within 28 days, respectively. Patients with a ≥30% increase above the baseline serum creatinine levels during visit 2 or 3 were followed every 2-4 weeks until a peak level of creatinine was detected.

Results posted on

2019-02-05

Participant Flow

Participant milestones

Participant milestones
Measure
Polyethylene Glycol (PEG)
3-L polyethylene glycol (PEG) is provided for colonoscopy preparation. Patients receive blood tests for renal function and electrolytes before and after colonoscopy. Polyethylene glycol (PEG): Participants receive blood tests for serum creatinine and electrolytes (Ca, P, Cl, Mg, Na, K) before and after taking polythylene glycol.
Overall Study
STARTED
1237
Overall Study
COMPLETED
1163
Overall Study
NOT COMPLETED
74

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Polyethylene Glycol (PEG)
n=1163 Participants
3L polyethylene glycol (PEG) is provided for colonoscopy preparation. Patients receive blood tests for renal function and electrolytes before and after colonoscopy. 3L Polyethylene glycol (PEG): Participants receive blood tests for serum creatinine and electrolytes (Ca, P, Cl, Mg, Na, K) before and after taking polythylene glycol.
Age, Continuous
55.7 years
STANDARD_DEVIATION 9.4 • n=1163 Participants
Sex: Female, Male
Female
623 Participants
n=1163 Participants
Sex: Female, Male
Male
540 Participants
n=1163 Participants

PRIMARY outcome

Timeframe: The durations between visits 1-2 and visits 2-3 were within 28 days, respectively. Patients with a ≥30% increase above the baseline serum creatinine levels during visit 2 or 3 were followed every 2-4 weeks until a peak level of creatinine was detected.

The screening visit (visit 1) induced a blood specimen for serum chemistry analysis. Immediately before the colonoscopy, study staff collected blood specimens for chemistry analysis (visit 2). The patients returned within 28 days after the colonoscopy for a final renal test (visit 3). Patients with a ≥30% increase above baseline creatinine levels during visit 2 or 3 were followed every 2-4 weeks until a peak level was detected (visit 4 and beyond).The serum creatinine level on visit 1 was recorded as the baseline renal function. The presence of renal injuries was determined by the highest serum creatinine level noted during the study period and included acute renal dysfunction, defined as a 30-49% increase above the baseline creatinine level, and acute kidney injury, defined as a ≥50% increase above the baseline serum creatinine. Number of participants with acute renal injury which included acute renal dysfunction and acute kidney injury will be recorded.

Outcome measures

Outcome measures
Measure
Polyethylene Glycol (PEG)
n=1163 Participants
A total of 1,163 patients completed the study protocol in which 3-L polyethylene glycol was used as colonoscopy preparation.
Number of Participants With Acute Renal Injury Which Included Acute Renal Dysfunction and Acute Kidney Injury
32 participants

SECONDARY outcome

Timeframe: The durations between visits 1-2 and visits 2-3 were within 28 days, respectively. Patients with electrolyte abnormalities during visit 2 or visit 3 were followed every 2-4 weeks until serum electrolyte values returned to normal.

The screening visit (visit 1) induced a blood specimen for serum chemistry analysis. Immediately before the colonoscopy, study staff collected blood specimens for chemistry analysis (visit 2). The patients returned within 28 days after the colonoscopy for a final renal safety evaluation (visit 3). Patients with electrolyte abnormalities during visit 2 or visit 3 were followed every 2-4 weeks until serum electrolyte values returned to normal.

Outcome measures

Outcome measures
Measure
Polyethylene Glycol (PEG)
n=1163 Participants
A total of 1,163 patients completed the study protocol in which 3-L polyethylene glycol was used as colonoscopy preparation.
Number of Participants With Acute Electrolyte Disturbance (Including Serum Caclium, Phosphate, Sodium, Potassium, Chloride, and Magnesium).
447 Participants

Adverse Events

Polyethylene Glycol (PEG)

Serious events: 0 serious events
Other events: 350 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Polyethylene Glycol (PEG)
n=1163 participants at risk
3-L polyethylene glycol (PEG) is provided for colonoscopy preparation. Patients receive blood tests for renal function and electrolytes before and after colonoscopy. Polyethylene glycol (PEG): Participants receive blood tests for serum creatinine and electrolytes (Ca, P, Cl, Mg, Na, K) before and after taking polythylene glycol.
General disorders
Any Electrolyte Abnormality
30.1%
350/1163 • Number of events 350 • Colonoscopy related complication was observed during and within one month after colonoscopy. Patient with acute renal injury were followed every 2-4 weeks until a peak level of creatinine was detected.Renal recovery was examined every month after the peak creatinine level was reached. Patients with electrolyte abnormalities during visit 2 or visit 3 were followed every 2-4 weeks until serum electrolyte values returned to normal.
General disorders
Hypocalcemia
25.8%
300/1163 • Number of events 300 • Colonoscopy related complication was observed during and within one month after colonoscopy. Patient with acute renal injury were followed every 2-4 weeks until a peak level of creatinine was detected.Renal recovery was examined every month after the peak creatinine level was reached. Patients with electrolyte abnormalities during visit 2 or visit 3 were followed every 2-4 weeks until serum electrolyte values returned to normal.
General disorders
Hypophosphatemia
12.0%
139/1163 • Number of events 139 • Colonoscopy related complication was observed during and within one month after colonoscopy. Patient with acute renal injury were followed every 2-4 weeks until a peak level of creatinine was detected.Renal recovery was examined every month after the peak creatinine level was reached. Patients with electrolyte abnormalities during visit 2 or visit 3 were followed every 2-4 weeks until serum electrolyte values returned to normal.
General disorders
Hyperchloremia
6.6%
77/1163 • Number of events 77 • Colonoscopy related complication was observed during and within one month after colonoscopy. Patient with acute renal injury were followed every 2-4 weeks until a peak level of creatinine was detected.Renal recovery was examined every month after the peak creatinine level was reached. Patients with electrolyte abnormalities during visit 2 or visit 3 were followed every 2-4 weeks until serum electrolyte values returned to normal.
General disorders
Hypokalemia
4.5%
52/1163 • Number of events 52 • Colonoscopy related complication was observed during and within one month after colonoscopy. Patient with acute renal injury were followed every 2-4 weeks until a peak level of creatinine was detected.Renal recovery was examined every month after the peak creatinine level was reached. Patients with electrolyte abnormalities during visit 2 or visit 3 were followed every 2-4 weeks until serum electrolyte values returned to normal.

Additional Information

Dr. Chiliang Cheng

Evergreen General Hospital

Phone: +886-3-4631230

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place